What does patient preference for pot over prescriptions mean for the pharma industry?

We track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the future

Six Sigma has the potential to deliver real cost savings by improving productivity and reducing defects, but making the change is challenging.

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion.

The industry is scrambling to find more about therapeutic modulation of checkpoint signals.

Brian recollects his early interest in science and discusses the latest trends in API manufacturing.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Donald Trump has vowed to lower drug prices, but what about his policies in other areas?

Martin Van Trieste tells the emotional story behind the creation of Rx-360

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?